TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials - a podcast by Synthego

TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases. 

Further episodes of CRISPR Cuts

Further podcasts by Synthego

Website of Synthego